uclahealth.org/clinical-tri...
For people previously treated with apalutamide, darolutamide, enzalutamide, abiraterone
It’s and ADC targeting B7-H3 checkpoint
clinicaltrials.gov/study/NC...
Targets PD1
phase 2 study for mCRPC: uclahealth.org... - Advanced Prostate...
phase 2 study for mCRPC
Written by
Maxone73
To view profiles and participate in discussions please or .
Read more about...
Not what you're looking for?
You may also like...
Good news for mCRPC (hopefully), phase 2
And here we go:
"mCRPC patients who have relapsed or are refractory to androgen receptor...
Phase 1-2 study for niclosamide-based drug:
…thought they made cars… 😜
“Hyundai’s formulation claims to have a high enough drug concentration...
Study on creatine and mCRPC: right on time!
They have posted the study outline here:...
AMG 212 Phase 1 study shows potential.
ASCO 2019: Phase 1 Study of Pasotuxizumab, a PSMA-Targeting Bispecific T cell Engager Immunotherapy...
PHASE 3 ECLIPSE STUDY FOR (MCRPC) PATIENTS- FIRST INFUSION OF Lutetium- 177
Just had my 1st infusion of Lutetium- 177, 3/9/23, in the Eclipse Trial.
Received 216.0 mCi of...
Related Posts
the phase II BATMAN study.
Anyone enter this Phase 3 Clincial Trial? Veru-111. https://clinicaltrials.gov/study/NCT04844749
Preventing Drug Resistance - Thinking Outside The Box - PRINT Phase 2 Study
Phase 1 study: New medicine extends terminally-ill cancer patients' lives
Enrolled in phase 2 clinical trail for neoadjuvant Enoblituzumab
